Study of the Safety, Tolerability, and Efficacy of an iPS Cell-based Therapy for Recessive Dystrophic Epidermolysis Bullosa Delivered with a Spray on Skin Device | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

Contact Us
If you have any questions or feedback please contact us.

Study of the Safety, Tolerability, and Efficacy of an iPS Cell-based Therapy for Recessive Dystrophic Epidermolysis Bullosa Delivered with a Spray on Skin Device

Biography

contributor

Co-Principal Investigator

Principal Investigator

Overview

sponsor award id

UG3AR082887

Time

start date

2023-09-01

end date

2024-08-31

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)